Although GLP-1 receptor agonists have demonstrated effectiveness in reducing weight loss and risks for other chronic diseases, questions remain over whether the benefits outweigh the harms of the drugs, including their cost-effectiveness and economic impact, Hannah Moll, a PhD candidate from the department of epidemiology at the University of Zurich in Switzerland, and colleagues, wrote in eClinicalMedicine
Journal of Endocrinology (2002) 4
Geschikt voor presentaties, congressen en bijeenkomsten
It was built from the ground up for people on medication, not retrofitted from a generic fitness tracker, and the difference shows
When we eat, food travels through the mouth, throat, esophagus, and stomach before ending up in the small intestine